BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19127291)

  • 1. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
    Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
    PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides derived from the HIV-1 integrase promote HIV-1 infection and multi-integration of viral cDNA in LEDGF/p75-knockdown cells.
    Levin A; Hayouka Z; Friedler A; Loyter A
    Virol J; 2010 Aug; 7():177. PubMed ID: 20678206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
    Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
    Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins.
    Levin A; Rosenbluh J; Hayouka Z; Friedler A; Loyter A
    Mol Med; 2010; 16(1-2):34-44. PubMed ID: 19855849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells.
    Levin A; Hayouka Z; Friedler A; Loyter A
    Nucleus; 2010; 1(5):422-31. PubMed ID: 21326825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
    Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
    J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein.
    Levin A; Hayouka Z; Friedler A; Loyter A
    Nucleus; 2010; 1(2):190-201. PubMed ID: 21326951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.
    Richetta C; Thierry S; Thierry E; Lesbats P; Lapaillerie D; Munir S; Subra F; Leh H; Deprez E; Parissi V; Delelis O
    J Biol Chem; 2019 May; 294(20):8286-8295. PubMed ID: 30971426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication.
    Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V
    Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
    Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
    Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism.
    Hayouka Z; Rosenbluh J; Levin A; Maes M; Loyter A; Friedler A
    Biopolymers; 2008; 90(4):481-7. PubMed ID: 18219678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.
    Sinha S; Grandgenett DP
    J Virol; 2005 Jul; 79(13):8208-16. PubMed ID: 15956566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
    Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
    PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
    Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
    J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.
    Chen H; Engelman A
    J Virol; 2000 Sep; 74(17):8188-93. PubMed ID: 10933731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization of human immunodeficiency virus type 1 preintegration complexes (PICs): V165A and R166A are pleiotropic integrase mutants primarily defective for integration, not PIC nuclear import.
    Limón A; Devroe E; Lu R; Ghory HZ; Silver PA; Engelman A
    J Virol; 2002 Nov; 76(21):10598-607. PubMed ID: 12368302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.
    Li X; Koh Y; Engelman A
    J Virol; 2012 Apr; 86(7):3861-79. PubMed ID: 22278243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import.
    Cribier A; Ségéral E; Delelis O; Parissi V; Simon A; Ruff M; Benarous R; Emiliani S
    Retrovirology; 2011 Dec; 8():104. PubMed ID: 22176773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
    Esposito D; Craigie R
    EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.
    Tsurutani N; Kubo M; Maeda Y; Ohashi T; Yamamoto N; Kannagi M; Masuda T
    J Virol; 2000 May; 74(10):4795-806. PubMed ID: 10775618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.